+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Artificial Intelligence in Biotechnology Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055666
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Artificial Intelligence in Biotechnology Market is projected to reach USD 7.54 Billion in 2026. It is expected to continue growing at a CAGR of 13.56%, reaching USD 16.11 Billion by 2032.

Artificial Intelligence Is Reshaping Biotechnology Across the Value Chain

Artificial intelligence (AI) is becoming an enabling layer across biotechnology, supporting target identification, protein and molecular design, clinical development, manufacturing, quality management, and regulatory documentation. Its role is expanding as biological datasets become larger and more complex, computing infrastructure improves, and organizations seek more reproducible ways to prioritize experiments and manage development risk. Adoption remains dependent on data quality, scientific validation, interoperability, cybersecurity, and responsible governance.

From Isolated Experiments to Integrated, Data-Centric Biotechnology

Biotechnology is shifting from siloed analytical workflows toward connected systems that combine omics, imaging, laboratory, clinical, and manufacturing data. Generative models and advanced analytics are helping researchers explore larger design spaces, while laboratory automation can translate computational hypotheses into repeatable experiments. The most consequential shift is organizational: successful deployment requires collaboration among biologists, data scientists, software engineers, clinicians, manufacturing specialists, and compliance teams.

AI’s Cumulative Impact Extends from Discovery Through Manufacturing

AI can accelerate prioritization in drug discovery, improve interpretation of biological signals, support biomarker development, and assist with clinical-trial design and patient stratification. In bioprocessing, it can help detect deviations, optimize operating conditions, and strengthen predictive maintenance. These benefits accumulate when models are connected across the product lifecycle, but they also create linked risks involving biased training data, weak explainability, model drift, intellectual property, privacy, and the need for human oversight at safety-critical decisions.

Regional Ecosystems Differ in Data Access, Regulation, and AI Readiness

North America combines deep biomedical research capacity, advanced computing, and substantial digital-health activity, while Latin America is emphasizing research collaboration, health-data modernization, and applications suited to local disease burdens. Europe is shaped by strong life-science institutions and a comparatively structured approach to trustworthy AI and data governance. The Middle East is investing in digital infrastructure and research capability, and Africa is applying AI selectively where it can strengthen diagnostics, surveillance, and health-system efficiency. Asia-Pacific presents a diverse landscape, spanning mature pharmaceutical and technology ecosystems, large clinical datasets, manufacturing strength, and rapidly developing innovation hubs. Across all regions, interoperability, skills, secure data access, and locally relevant validation remain decisive.

Major Economic and Security Groupings Set Different Conditions for Adoption

ASEAN’s diverse regulatory and infrastructure environment makes cross-border standards and interoperable data practices especially important. BRICS members combine substantial scientific, manufacturing, and population-scale capabilities, while differences in governance and technical maturity influence collaboration. The European Union emphasizes common rules, privacy, and trustworthy deployment; the G7 focuses on advanced research, standards, resilience, and responsible innovation. GCC countries are strengthening digital infrastructure and biotechnology capacity through coordinated investment, and NATO members increasingly consider biotechnology and AI through the lenses of health security, supply-chain resilience, and dual-use governance.

Country Priorities Range from Frontier Research to Health-System Deployment

Australia is developing AI-enabled biomedical research and health-data capabilities, while Brazil and Mexico are focusing on applications aligned with public-health needs and expanding research networks. Canada emphasizes coordinated life-science research, responsible data use, and translational capacity. China is advancing AI, biomedical research, and biomanufacturing at scale; Japan and South Korea combine strong technology sectors with sophisticated healthcare and manufacturing systems. India is expanding digital health, computational biology, and cost-sensitive innovation. France, Germany, Italy, Spain, and the United Kingdom bring established research and pharmaceutical ecosystems, with growing attention to regulation, clinical validation, and industrial adoption. The United States remains a major center for biomedical research, AI development, venture activity, and advanced life-science infrastructure. Russia maintains relevant scientific and engineering capabilities, although access to international partnerships, equipment, and data can affect deployment conditions.

Leaders Should Build Governed, Interoperable AI Capabilities Around High-Value Use Cases

Industry leaders should begin with measurable problems such as experiment prioritization, quality monitoring, trial recruitment, or process optimization rather than deploying AI without a defined operating need. Establish common data standards, lineage controls, access policies, and validation protocols before scaling models. Pair domain experts with technical teams, test performance across relevant populations and operating conditions, monitor drift, and document human accountability. Partnerships with research institutions and technology providers can expand capability, but organizations should protect sensitive data, assess intellectual-property exposure, and maintain fallback procedures for critical workflows. Workforce training and change management are as important as model selection.

Methodology Combines Structured Review with Triangulation of Verified Evidence

This executive summary is based on a structured assessment of how AI is applied across biotechnology activities, including research, development, clinical operations, manufacturing, and governance. Findings are synthesized from publicly available scientific literature, regulatory and policy materials, institutional publications, industry disclosures, and regional technology and life-science sources. Regional, group, and country comparisons consider research capacity, digital infrastructure, data governance, biotechnology activity, and adoption conditions. Evidence was interpreted qualitatively, with emphasis on recurring, verifiable patterns rather than unsupported numerical claims.

Responsible Integration Will Determine Biotechnology’s AI Advantage

AI is moving biotechnology toward faster, more connected, and more data-driven decision-making, but technical capability alone will not ensure durable value. Organizations that combine rigorous validation, secure and interoperable data foundations, cross-functional expertise, and clear accountability will be better positioned to convert AI experimentation into dependable scientific and operational outcomes. Progress will remain strongest where innovation is matched by transparent governance, equitable access, and sustained investment in people and infrastructure.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Intelligence in Biotechnology Market, by Component
7.1. Introduction
7.2. Services
7.2.1. Consulting & Implementation
7.2.2. Post-Sales & Maintenance Services
7.2.3. Training & Education Services
7.3. Solutions
8. Artificial Intelligence in Biotechnology Market, by Technology
8.1. Introduction
8.2. Deep Learning
8.3. Machine Learning
8.4. Natural Language Processing
8.5. Neural Networks
8.6. Robotic Process Automation
9. Artificial Intelligence in Biotechnology Market, by Data Type
9.1. Introduction
9.2. Clinical Data
9.3. Genomic Data
9.4. Imaging Data
9.5. Proteomic Data
10. Artificial Intelligence in Biotechnology Market, by Pricing Model
10.1. Introduction
10.2. Freemium
10.3. Licensing
10.4. Pay Per Use
11. Artificial Intelligence in Biotechnology Market, by Application
11.1. Introduction
11.2. Agriculture Biotechnology
11.3. Clinical Diagnostics
11.4. Drug Discovery
11.5. Genomics Analysis
11.6. Precision Medicine
12. Artificial Intelligence in Biotechnology Market, by End-User
12.1. Introduction
12.2. Agricultural Institutes
12.3. Biotechnology Firms
12.4. Contract Research Organizations
12.5. Diagnostic Laboratories
12.6. Hospitals & Clinics
12.7. Pharmaceutical Companies
12.8. Research & Academic Institutions
13. Artificial Intelligence in Biotechnology Market, by Therapeutic Area
13.1. Introduction
13.2. Cardiovascular
13.3. Immunology
13.4. Infectious Diseases
13.5. Neurology
13.6. Oncology
13.7. Rare Diseases
14. Artificial Intelligence in Biotechnology Market, by Deployment Mode
14.1. Introduction
14.2. Cloud
14.3. On-Premises
15. Artificial Intelligence in Biotechnology Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Artificial Intelligence in Biotechnology Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Artificial Intelligence in Biotechnology Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Aitia
19.2. ARIA’S SCIENCE
19.3. Atomwise, Inc.
19.4. BenevolentAI Limited
19.5. BioNTech SE
19.6. BioXcel Therapeutics, Inc.
19.7. BPGbio, Inc.
19.8. Capgemini SE
19.9. Cloud Pharmaceuticals
19.10. Cytel, Inc.
19.11. CytoReason, Ltd.
19.12. Deep Genomics Inc.
19.13. Envisagenics
19.14. Exscientia, plc
19.15. Fujitsu Limited
19.16. Genesis Therapeutics, Inc.
19.17. Genialis, Inc.
19.18. Google LLC by Alphabet Inc.
19.19. HitGen Inc.
19.20. Illumina Inc.
19.21. InSilico Medicine
19.22. Insitro, Inc.
19.23. NuMedii, Inc.
19.24. NVIDIA Corporation
19.25. Owkin, Inc.
19.26. PathAI, Inc.
19.27. Recursion Pharmaceuticals, Inc.
19.28. Schrödinger, Inc.
19.29. Tempus Labs, Inc.
19.30. Valo Health, LLC
19.31. Verge Genomics, Inc.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Artificial Intelligence in Biotechnology Market, Years Considered for the Study
FIGURE 2. Global Artificial Intelligence in Biotechnology Market, Research Design
FIGURE 3. Global Artificial Intelligence in Biotechnology Market, Research Framework
FIGURE 4. Global Artificial Intelligence in Biotechnology Market, Data Triangulation
FIGURE 5. Global Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Artificial Intelligence in Biotechnology Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Artificial Intelligence in Biotechnology Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Artificial Intelligence in Biotechnology Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Artificial Intelligence in Biotechnology Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Artificial Intelligence in Biotechnology Market Size, by Data Type, 2025 vs 2032 (%)
FIGURE 11. Global Artificial Intelligence in Biotechnology Market Size, by Data Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2025 vs 2032 (%)
FIGURE 13. Global Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Artificial Intelligence in Biotechnology Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Artificial Intelligence in Biotechnology Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Artificial Intelligence in Biotechnology Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 17. Global Artificial Intelligence in Biotechnology Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 19. Global Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 21. Global Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Artificial Intelligence in Biotechnology Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Artificial Intelligence in Biotechnology Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Artificial Intelligence in Biotechnology Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Artificial Intelligence in Biotechnology Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Artificial Intelligence in Biotechnology Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Artificial Intelligence in Biotechnology Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Artificial Intelligence in Biotechnology Market Segmentation & Coverage
TABLE 2. Global Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 3. Global Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Consulting & Implementation Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Consulting & Implementation Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Consulting & Implementation Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Post-Sales & Maintenance Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Post-Sales & Maintenance Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Post-Sales & Maintenance Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Training & Education Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Training & Education Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Training & Education Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 20. Global Deep Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Deep Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Deep Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Machine Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Machine Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Machine Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Natural Language Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Natural Language Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Natural Language Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Neural Networks Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Neural Networks Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Neural Networks Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Robotic Process Automation Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Robotic Process Automation Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Robotic Process Automation Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 36. Global Clinical Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Clinical Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Clinical Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Genomic Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Genomic Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Genomic Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Imaging Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Imaging Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Imaging Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Proteomic Data Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Proteomic Data Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Proteomic Data Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 49. Global Freemium Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Freemium Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Freemium Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Licensing Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Licensing Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Licensing Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pay Per Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Pay Per Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Pay Per Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 59. Global Agriculture Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Agriculture Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Agriculture Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Genomics Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Genomics Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Genomics Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Precision Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Precision Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Precision Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 75. Global Agricultural Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Agricultural Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Agricultural Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Biotechnology Firms Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Biotechnology Firms Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Biotechnology Firms Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Research & Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Research & Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Research & Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 97. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Immunology Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Immunology Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Immunology Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Rare Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Rare Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Rare Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 116. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global On-Premises Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global On-Premises Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global On-Premises Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Artificial Intelligence in Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 133. North America Artificial Intelligence in Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. North America Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 135. North America Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 136. North America Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 137. North America Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 138. North America Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 139. North America Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. North America Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 141. North America Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 142. North America Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 143. Latin America Artificial Intelligence in Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Latin America Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 145. Latin America Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 146. Latin America Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 147. Latin America Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 148. Latin America Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 149. Latin America Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Latin America Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 151. Latin America Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 152. Latin America Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 153. Europe Artificial Intelligence in Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Europe Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 155. Europe Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 156. Europe Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 157. Europe Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 158. Europe Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 159. Europe Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Europe Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 161. Europe Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 162. Europe Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 163. Middle East Artificial Intelligence in Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Middle East Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 165. Middle East Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 166. Middle East Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. Middle East Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 168. Middle East Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 169. Middle East Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Middle East Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 171. Middle East Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 172. Middle East Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 173. Africa Artificial Intelligence in Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Africa Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 175. Africa Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 176. Africa Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. Africa Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 178. Africa Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 179. Africa Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Africa Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 181. Africa Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 182. Africa Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 183. Global Artificial Intelligence in Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. ASEAN Artificial Intelligence in Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. ASEAN Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 186. ASEAN Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 187. ASEAN Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. ASEAN Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 189. ASEAN Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 190. ASEAN Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. ASEAN Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 192. ASEAN Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 193. ASEAN Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 194. GCC Artificial Intelligence in Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. GCC Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 196. GCC Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 197. GCC Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 198. GCC Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 199. GCC Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 200. GCC Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. GCC Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 202. GCC Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 203. GCC Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 204. European Union Artificial Intelligence in Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. European Union Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 206. European Union Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 207. European Union Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. European Union Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 209. European Union Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 210. European Union Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. European Union Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 212. European Union Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 213. European Union Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 214. BRICS Artificial Intelligence in Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 215. BRICS Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 216. BRICS Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 217. BRICS Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. BRICS Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 219. BRICS Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 220. BRICS Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. BRICS Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 222. BRICS Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 223. BRICS Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 224. G7 Artificial Intelligence in Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. G7 Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 226. G7 Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 227. G7 Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. G7 Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 229. G7 Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 230. G7 Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. G7 Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 232. G7 Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 233. G7 Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 234. NATO Artificial Intelligence in Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. NATO Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 236. NATO Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 237. NATO Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. NATO Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 239. NATO Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 240. NATO Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. NATO Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 242. NATO Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 243. NATO Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 244. Global Artificial Intelligence in Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 245. United States Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 246. United States Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 247. United States Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 248. United States Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. United States Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 250. United States Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 251. United States Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. United States Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 253. United States Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 254. United States Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 255. Canada Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 256. Canada Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 257. Canada Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 258. Canada Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 259. Canada Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 260. Canada Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 261. Canada Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Canada Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 263. Canada Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 264. Canada Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 265. Mexico Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 266. Mexico Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 267. Mexico Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 268. Mexico Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. Mexico Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 270. Mexico Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 271. Mexico Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. Mexico Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 273. Mexico Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 274. Mexico Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 275. Brazil Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 276. Brazil Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 277. Brazil Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 278. Brazil Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 279. Brazil Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 280. Brazil Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 281. Brazil Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. Brazil Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 283. Brazil Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 284. Brazil Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 285. United Kingdom Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 286. United Kingdom Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 287. United Kingdom Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 288. United Kingdom Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 289. United Kingdom Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 290. United Kingdom Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 291. United Kingdom Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. United Kingdom Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 293. United Kingdom Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 294. United Kingdom Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 295. Germany Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 296. Germany Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 297. Germany Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 298. Germany Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 299. Germany Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 300. Germany Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 301. Germany Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. Germany Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 303. Germany Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 304. Germany Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 305. France Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 306. France Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 307. France Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 308. France Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 309. France Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 310. France Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD Million)
TABLE 311. France Artificial Intelligence in Biotechnology Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. France Artificial Intelligence in Biotechnology Market Size, by End-User, 2017-2032 (USD Million)
TABLE 313. France Artificial Intelligence in Biotechnology Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 314. France Artificial Intelligence in Biotechnology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 315. Russia Artificial Intelligence in Biotechnology Market Size, 2017-2032 (USD Million)
TABLE 316. Russia Artificial Intelligence in Biotechnology Market Size, by Component, 2017-2032 (USD Million)
TABLE 317. Russia Artificial Intelligence in Biotechnology Market Size, by Services, 2017-2032 (USD Million)
TABLE 318. Russia Artificial Intelligence in Biotechnology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 319. Russia Artificial Intelligence in Biotechnology Market Size, by Data Type, 2017-2032 (USD Million)
TABLE 320. Russia Artificial Intelligence in Biotechnology Market Size, by Pricing Model, 2017-2032 (USD

Companies Mentioned

  • Aitia
  • ARIA’S SCIENCE
  • Atomwise, Inc.
  • BenevolentAI Limited
  • BioNTech SE
  • BioXcel Therapeutics, Inc.
  • BPGbio, Inc.
  • Capgemini SE
  • Cloud Pharmaceuticals
  • Cytel, Inc.
  • CytoReason, Ltd.
  • Deep Genomics Inc.
  • Envisagenics
  • Exscientia, plc
  • Fujitsu Limited
  • Genesis Therapeutics, Inc.
  • Genialis, Inc.
  • Google LLC by Alphabet Inc.
  • HitGen Inc.
  • Illumina Inc.
  • InSilico Medicine
  • Insitro, Inc.
  • NuMedii, Inc.
  • NVIDIA Corporation
  • Owkin, Inc.
  • PathAI, Inc.
  • Recursion Pharmaceuticals, Inc.
  • Schrödinger, Inc.
  • Tempus Labs, Inc.
  • Valo Health, LLC
  • Verge Genomics, Inc.